Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Diabetes PHGKB

Specific PHGKB|Diabetes PHGKB|PHGKB

Last Posted: Nov 18, 2022
spot light Spotlight

Aiming for equitable precision medicine in diabetes.
et al. Nature medicine 2022 11 (11) 2223

New initiatives aimed at reducing the burden of diabetes are laudable, but they will have to account for the disease’s complexity and heterogeneity to be truly effective and equitable at a global scale. A growing body of evidence supports the idea that variation exists not only in disease presentation and progression but also in individual responses to therapy, which suggests that a ‘one-size-fits-all’ approach to meeting the global coverage targets will be insufficient.

Broad-capture proteomics and machine learning for early detection of type 2 diabetes risk
Nature Medicine, November 10, 2022

Impaired glucose tolerance (IGT) is a common condition that affects glucose control after sugar consumption. Isolated IGT is undetected by screening and diagnostic strategies, leaving affected individuals at high risk of developing diabetes. Here, a machine-learning framework identifies a three-protein signature for detecting isolated IGT from a single blood sample.

Proteomic signatures for identification of impaired glucose tolerance
JC Zanini et al, Nature Medicine, November 10, 2022

We applied machine learning to the proteomic profiles of a single fasted sample from 11,546 participants of the Fenland study to test discrimination of iIGT defined using the gold-standard OGTTs. We observed significantly improved discriminative performance by adding only three proteins (RTN4R, CBPM and GHR) to the best clinical model (AUROC = 0.80 (95% confidence interval: 0.79–0.86), P?=?0.004), which we validated in an external cohort. Increased plasma levels of these candidate proteins were associated with an increased risk for future T2D in an independent cohort and were also increased in individuals genetically susceptible to impaired glucose homeostasis and T2D.

Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney disease
I W Wu et al, NPJ Digital Medicine, November 2, 2022

Diabetic kidney disease is the leading cause of end-stage kidney disease worldwide; however, the integration of high-dimensional trans-omics data to predict this diabetic complication is rare. We develop artificial intelligence (AI)-assisted models using machine learning algorithms to identify a biomarker signature that predisposes high risk patients with diabetes mellitus (DM) to diabetic kidney disease based on clinical information, untargeted metabolomics, targeted lipidomics and genome-wide single nucleotide polymorphism (SNP) datasets. This involves 618 individuals who are split into training and testing cohorts of 557 and 61 subjects, respectively.


news Latest News and Publications
Improving Machine Learning Diabetes Prediction Models for the Utmost Clinical Effectiveness External Web Site Icon
J Shin et al, J Per Med, November 14, 2022
Diabetes and Alzheimer's disease: shared genetic susceptibility? External Web Site Icon
J Hardy et al, The Lancet Neurology, November 1, 2022
Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis. External Web Site Icon
Edward Justin A et al. Cardiovascular diabetology 2022 21(1) 58
Machine learning approaches to predict the 1-year-after-initial-AMI survival of elderly patients. External Web Site Icon
Lee Jisoo et al. BMC medical informatics and decision making 2022 22(1) 115
Long-term Prediction of Blood Glucose Levels in Type 1 Diabetes Using a CNN-LSTM-Based Deep Neural Network. External Web Site Icon
Jaloli Mehrad et al. Journal of diabetes science and technology 2022 19322968221092785
Risk Prediction of Pancreatic Cancer in Patients With Recent-onset Hyperglycemia: A Machine-learning Approach. External Web Site Icon
Chen Wansu et al. Journal of clinical gastroenterology 2022
Association of Lipoprotein (a) in Coronary Artery Disease in Young Individuals. External Web Site Icon
Patted Aishwarya et al. The Journal of the Association of Physicians of India 2022 70(4) 11-12
Development of a clinical polygenic risk score assay and reporting workflow. External Web Site Icon
Hao Limin et al. Nature medicine 2022
Polygenic risk score as a possible tool for identifying familial monogenic causes of complex diseases. External Web Site Icon
Lu Tianyuan et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022
Preconception leisure-time physical activity and family history of stroke and myocardial infarction associate with preterm delivery: findings from a Norwegian cohort. External Web Site Icon
Engen Tone et al. BMC pregnancy and childbirth 2022 22(1) 341

More

About Diabetes PHGKB

Diabetes PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to diabetes...more

Content Summary

Common Diabetes Related Topics

Quick Links


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

TOP